Hyowon Lee, MSc
PhD Candidate

He received his master degree from Dongguk University and studied plant genetics. He worked as a research intern in a neuroscience lab at Fred Hutchinson Cancer Research Center. Currently, he is studying neuroscience in Nam lab at KIST as a PhD student.


  • Best oral presentation award at 2022 KIST BSI Annual Workshop
  • Best poster presentation award at 2022 International conference of Korea Society of Brain and Neural Science (KSBNS) 
  • Best poster presentation award at 2021 KIST BSI Annual Workshop


  1. Oh JY*, Lee H*, Jang SY, Kim H, Park G, Serikov A, Jang JH, Kim J, Yang S, Sa M, Lee SE, Han YE, Hwang TY, Kim HY, Lee SE, Oh SJ, Kim J, Kim J, Lee CJ, Nam MH#, Park HJ#, Discrete projections from MCH neurons mediate anti-parkinsonian effects of acupuncture, BioRxiv, 2023, DOI: 10.1101/2023.06.07.543987  (#co-corresponding authors)
  2. Nam MH*, Ko HY*, Kim D*, Lee S, Park YM, Hyeon SJ, Won W, Chung JI, Kim SY, Jo HH, Oh KT, Han YE, Lee GH, Ju YH, Lee H, Kim H, Heo J, Bhalla M, Kim KJ, Kwon J, Stein TD, Kong M, Lee H, Lee SE, Oh SJ, Chun JH, Park MA, Park KD, Ryu H#, Yun M#, Lee CJ#, Visualization reactive astrocyte-neuron interaction in Alzheimer’s disease using 11C-acetate and 18F-FDG, Brain, 2023, DOI: 10.1093/brain/awad037 (selected as Editor's choice)
  3. Kim H, Nam MH, Jeong S, Lee H, Oh SJ, Kim J, Choi N, Seong J#, Visualization of differential GPCR crosstalk in DRD1-DRD2 heterodimer upon different dopamine levels, Progress in Neurobiology, 2022, https://doi.org/10.1016/j.pneurobio.2022.102266
  4. An H, Lee H, Yang S, Won W, Lee CJ#, Nam MH#, Adenovirus-induced reactive astrogliosis exacerbates the pathology of Parkinson's disease, Experimental Neurobiology, 2021;30(3):222-231.  DOI: 10.5607/en21013 (#co-corresponding authors)
  5. Nam MH*, Park JH*, Song HJ*, Choi JW, Kim S, Jang BK, Yoon HH, Heo JY, Lee H, An H, Kim H, Park SJ, Cho DW, Yang YS, Han SC, Kim S, Oh SJ, Jeon SR, Park KD#, Lee CJ#, KDS2010, a newly developed reversible MAO-B inhibitor, as an effective therapeutic candidate for Parkinson’s disease, Neurotherapeutics, 2021;18(3):1729-1747. DOI: 10.1007/s13311-021-01097-4